TMC Life Sciences Berhad reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was MYR 93.78 million compared to MYR 73.34 million a year ago. Net income was MYR 14.52 million compared to MYR 5.49 million a year ago. Basic earnings per share from continuing operations was MYR 0.0083 compared to MYR 0.0032 a year ago. Diluted earnings per share from continuing operations was MYR 0.0083 compared to MYR 0.0032 a year ago.
For the six months, sales was MYR 186.22 million compared to MYR 145.21 million a year ago. Net income was MYR 29.66 million compared to MYR 11.72 million a year ago. Basic earnings per share from continuing operations was MYR 0.017 compared to MYR 0.0067 a year ago. Diluted earnings per share from continuing operations was MYR 0.017 compared to MYR 0.0067 a year ago.